Dual drug release from core-shell nanoparticles with distinct release profiles

Journal of Pharmaceutical Sciences

Volumn 103, Issue 10, 2014, Pages 3205-3216

  Cao, Yang ^a,b   Wang, Bochu ^a   Wang, Yazhou ^a   Lou, Deshuai ^a  

^a CHONGQING UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Biomaterials; Controlled release delivery; Core shell nanoparticles; Distinct release profiles; Dual drug encapsulation; Nanoparticles; Nanotechnology; Polymeric drug carrier

Indexed keywords

ANTINEOPLASTIC AGENT; DRUG CARRIER; NANOPARTICLE; POLYMER;

ANTINEOPLASTIC AGENTS; DRUG CARRIERS; NANOPARTICLES; POLYMERS;

EID: 84930152698     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.24116     Document Type: Article

References (58)

1. Gottesman MM. 2002. Mechanisms of cancer drug resistance. Annu Rev Med 53:615-627.
2. Aryal S, Hu CM, Zhang L. 2011. Polymeric nanoparticles with precise ratiometric control over drug loading for combination therapy. Mol Pharm 8:1401-1407.
3. Qiu LY, Bae YH. 2001. Self-assembled polyethylenimine-graft-poly (g -caprolactone) micelles as potential dual carriers of genes and anticancer drugs. Biomaterials 28:4132-4142.
4. Wei L, Cai C, Lin J, Chen T. 2009. Dual-drug delivery system based on hydrogel/micelle composites. Biomaterials 30:2606-2613.
5. Zhang L, Gu FX, Chan JM, Wang AZ, Langer RS, Farokhzad OC. 2007. Co-delivery of hydrophobic and hydrophilic drugs from nanoparticle-aptamer bioconjugates. Chem Med Chem 2:1268-1271.
6. Walsh C. 2000. Molecularmechanisms that confer antibacterial drug resistance. Nature 406:775-781.
7. Lee JS, Bae JW, Joung YK, Lee SJ, Han DK, Park KD. 2008. Controlled dual release of basic fibroblast growth factor and indomethacin from heparin-conjugated polymeric micelle. Int J Pharm 346:57-63.
8. Wang Y, Gao SJ, Ye WH, Yoon HS, Yang YY. 2006. Co-delivery of drugs and DNA from cationic core-shell nanoparticles self-assembled from a biodegradable copolymer. Nat Mater 5:791-796.
9. Song XR, Cai Z, Zheng Y, He G, Cui FY, Gong DQ, Hou SX, Xiong SJ, Lei XJ, Wei YQ. 2009. Reversion of multidrug resistance by coencapsulation of vincristine and verapamil in PLGA nanoparticles. Eur J Pharm Sci 37:300-305.
10. Ahmed F, Pakunlu RI, Brannan A, Bates F, Minko T, Discher DE.2006. Biodegradable polymersomes loaded with both paclitaxel and doxorubicin permeate and shrink tumors, inducing apoptosis in proportion to accumulated drug. J Control Release 116:150-158.
11. Lammers T, Subr V, Ulbrich K, Peschke P, Huber PE, Hennink WE, Storm G. 2009. Simultaneous delivery of doxorubicin and gemcitabine to tumors in vivo using prototypic polymeric drug carriers. Biomaterials 30:3466-3475.
12. Sengupta S, Eavarone D, Capila I, Zhao G, Watson N, Kiziltepe T, Sasisekharan R. 2005. Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system. Nature 436:568-572.
13. Richardson TP, Peters MC, Ennett AB, Mooney DJ. 2001. Polymeric system for dual growth factor delivery. Nat Biotechnol 19:1029-1034.
14. Chen FM, Zhao YM, Wu H, Deng ZH, Wang QT, Jin Y. 2006.Enhancement of periodontal tissue regeneration by locally controlled delivery of insulin-like growth factor-I from dextran-co-gelatin microspheres. J Control Release 114:209-222.
15. Young S, Wong M, Tabata Y, Mikos AG. 2005. Gelatin as a delivery vehicle for the controlled release of bioactive molecules. J Control Release 109:256-274.
16. Wei HJ, Yang HH, Chen CH, Lin WW, Chen SC, Sung HW.2007. Gelatinmicrospheres encapsulated with a nonpeptide angiogenic agent, ginsenoside Rg1, for intramyocardial injection in a rat model with infarcted myocardium. J Control Release 120:27-34.
17. Delcea M, Yashchenok A, Videnova K, Kreft O, Mohwald H, Skirtach AG. 2010. Multicompartmental micro- and nanocapsules: Hierarchy and applications in biosciences. Macromol Biosci 10:465-474.
18. Baumler H, Georgieva R. 2010. Coupled enzyme reactions in multicompartment microparticles. Biomacromolecules 11:1480-1487.
19. Tran VT, Benoît JP, Venier-Julienne MC. 2011. Why and how to prepare biodegradable, monodispersed, polymeric microparticles in the field of pharmacy? Int J Pharm 407:1-11.
20. Yuan F, Dellian M, Fukumura D, Leunig M, Berk DA, Torchilin VP, Jain RK. 1995. Vascular permeability in a human tumor xenograft: Molecular size dependence and cutoff size. Cancer Res 55:3752-3756.
21. Hu CMJ, Aryal S, Zhang L. 2010. Polymeric nanoparticles with precise ratiometric control over drug loading for combination therapy. Ther Deliv 1:321-334.
22. Bohr A, Yang M, Baldursdóttir S, Kristensen J, Dyas M, Stride E, Edirisinghe M. 2012. Particle formation and characteristics of Celecoxib-loaded poly (lactic-co-glycolic acid) microparticles prepared in different solvents using electrospraying. Polymer 15:3220-3229.
23. Rosca ID, Watari F, Uo M. 2004. Microparticle formation and its mechanism in single and double emulsion solvent evaporation. J Control Release 99:271-280.
24. Tamber H, Johansen P, Merkle HP, Gander B. 2005. Formulation aspects of biodegradable polymeric microspheres for antigen delivery. Adv Drug Deliv Rev 57:357-376.
25. Valo H, Peltonen L, Vehviläinen S, Karjalainen M, Kostiainen R, Laaksonen T, Hirvonen J. 2009. Electrospray encapsulation of hydrophilic and hydrophobic drugs in poly(L-lactic acid) nanoparticles. Small 5:1791-1798.
26. Xie J, Marijnissen J, Wang CH. 2006. Microparticles developed by electrohydrodynamic atomization for the local delivery of anticancer drug to treat C6 glioma in vitro. Biomaterials 27:3321-3332.
27. Xu Y, Hanna MA. 2006. Electrospray encapsulation of watersoluble protein with polylactide: Effects of formulations on morphology, encapsulation efficiency and release profile of particles. Int J Pharm 320:30-36.
28. Jaworek A, Sobczyk AT. 2008. Electrospraying route to nanotechnology: An overview. J Electrostatics 66:197-219.
29. Zhang S, Kawakami K, Yamamoto M, Masaoka Y, Kataoka M, Yamashita S, Sakuma S. 2011. Coaxial electrospray formulations for improving oral absorption of a poorly water-soluble drug. Mol Pharmaceutics 8:807-813.
30. Su Y, Su Q, Liu W, Lim M, Venugopal JR, Mo X, Ramakrishna S, Al-Deyabe SS, El-Newehy M. 2012. Controlled release of bone morphogenetic protein 2 and dexamethasone loaded in core-shell PLLACL-collagen fibers for use in bone tissue engineering. Acta Biomater 8:763-771.
31. Okuda T, Tominaga K, Kidoaki S. 2010. Time-programmed dual release formulation by multilayered drug-loaded nanofiber meshes. J Control Release 143:258-264.
32. Cui W, Li X, Zhu X, Yu G, Zhou S, Weng J. 2006. Investigation of drug release and matrix degradation of electrospun poly (DL-lactide) fibers with paracetanol inoculation. Biomacromolecules 7:1623-1629.
33. Su Y, Li XQ, Tan LJ, Huang C, Mo XM. 2009. Controlled release of bone morphogenetic protein 2 and dexamethasone loaded in core-shell PLLACL-collagen fibers for use in bone tissue engineering. Polymer 50:4212-4219.
34. Chew SY, Wen J, Yim EKF, Leong KW. 2005. Sustained release of proteins from electrospun biodegradable fibers. Biomacromolecules 6:2017-2024.
35. Singh A, Dilnawaz F, Mewar S, Sharma U, Jagannathan NR, Sahoo SK. 2011. Composite polymeric magnetic nanoparticles for co-delivery of hydrophobic and hydrophilic anticancer drugs and MRI imaging for cancer therapy. Appl Mater Interfaces 3:842-856.
36. Zhang YZ, Wang X, Feng Y, Li J, Lim CT, Ramakrishna S.2006. Coaxial electrospinning of (fluorescein isothiocyanate-conjugated bovine serum albumin)-encapsulated poly (g-caprolactone) nanofibers for sustained release. Biomacromolecules 7:1049-1057.
37. Nie H, Fu Y, Wang CH. 2010. Paclitaxel and suramin-loaded core/shell microspheres in the treatment of brain tumors. Biomaterials 31:8732-8740.
38. Walsh C. 2000. Molecular mechanisms that confer antibacterial drug resistance. Nature 406:775-781.
39. Acharya G, Shin CS, Vedantham K, McDermott M, Rish T, Hansen K, Fu Y, Park K. 2010. A study of drug release from homogeneous PLGA microstructures. J Control Release 146:201-206.
40. Virto MR, Elorza B, Torrado S, Elorza ML, Frutos G. 2007. Improvement of gentamicin poly(d,l-lactic-co-glycolic acid) microspheres for treatment of osteomyelitis induced by orthopedic procedures. Biomaterials 28:877-885.
41. Xu J, Jiao Y, Shao X, Zhou C. 2011. Controlled dual release of hydrophobic and hydrophilic drugs from electrospun poly (L-lactic acid) fiber mats loaded with chitosan microspheres. Mater Lett 65:2800-2803.
42. Peltonen L, Aitta J, Hyvönen S, Karjalainen M, Hirvonen J. 2004.Improved entrapment efficiency of hydrophilic drug substance during nanoprecipitation of poly(I) lactide nanoparticles. AAPS PharmSciTech 5:115-120.
43. Strobel C, Bormann N, Kadow-Romacker A, Schmidmaier G,Wildemann B. 2011. Sequential release kinetics of two (gentamicin and BMP-2) or three (gentamicin, IGF-I and BMP-2) substances from a onecomponent polymeric coating on implants. J Control Release 156:37-45.
44. Fredenberg S,Wahlgren M, Reslow M, Axelsson A. 2011. Themechanisms of drug delivery in poly(lactic-co-glycolic-acid)-based drug delivery system- review. Int J Pharm 415:34-52.
45. Fischbach C, Mooney DJ. 2007. Polymers for pro-and antiangiogenic therapy. Biomaterials 28:2069-2076.
46. Bock N, Woodruff MA, Hutmacher DW, Dargaville TR. 2011. Electrospraying, a reproducible method for production of polymeric microspheres for biomedical applications. Polymer 3:131-149.
47. Yao J, Lim LK, Xie J, Hua J, Wang CH. 2008. Characterization of electrospraying process for polymeric particle fabrication. J Aerosol Sci 39:987-1002.
48. Wu Y, Yu B, Jackson A, Zha W, Lee LJ,Wyslouzil BE. 2009. Coaxial electrohydrodynamic spraying: A novel one-step technique to prepare oligodeoxynucleotide encapsulated lipoplex nanoparticles. Mol Pharmaceutics 6:1371-1379.
49. Lee YH, Bai MY, Chen DR. 2011. Multidrug encapsulation by coaxial tri-capillary electrospray. Colloid Surf B 82:104-110.
50. Lee WL, Yu P, Hong M, Widjaja E, Loo SCJ. 2012. Designing multilayered particulate systems for tunable drug release profiles. Acta Biomater 8:2271-2278.
51. Xie J, Wang CH. 2007. Encapsulation of proteins in biodegradable polymeric microparticles using electrospray in the Taylor cone-jet mode. Biotechnol Bioeng 97:1278-1290.
52. Lee YH, Mei F, Bai MY, Zhao S, Chen DR. 2010. Release profile characteristics of biodegradable-polymer-coated drug particles fabricated by dual-capillary electrospray. J Control Release 145:58-65.
53. Li C, Cheng L, Zhang Y, Guo S, Wu W. 2010. Effects of implant diameter, drug loading and end-capping on praziquantel release from PCL implants. Int J Pharm 386:23-29.
54. Miao YE, Zhu H, Chen D, Wang R, Tjiu WW, Liu T. 2012. Electrospun fibers of layered double hydroxide/biopolymer nanocomposites as effective drug delivery systems. Mater Chem Phys 134(2-3):623-630.
55. Kim W, Kim SS. 2011. Synthesis of biodegradable triple-layered capsules using a triaxial electrospray method. Polymer 52:3325-3336.
56. Tieppo A, White CJ, Paine AC, Voyles ML, McBride MK, Byrne ME. 2012. Sustained in vivo release from imprinted therapeutic contact lenses. J Control Release 157(3):391-397.
57. Yu DG, Wang X, Li XY, Chian W, Li Y, Liao YZ. 2013. Electrospun biphasic drug release polyvinylpyrrolidone/ethyl cellulose core/sheath nanofibers. Acta Biomater 9:5665-5672.
58. Ruan G, Feng SS. 2004. Preparation and characterization of poly (lactic acid)-poly (ethylene glycol)-poly (lactic acid)(PLA-PEG-PLA) microspheres for controlled release of paclitaxel. Biomaterials 24:5037-5044.